Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
rivaroxaban (xarelto) (1 trial)
warfarin (coumadin) (1 trial)
sacubitril (Entresto) (1 trial)
valsartan (diovan) (1 trial)
Blood Coagulation Disorders (Phase 3)
Heart Diseases (Phase 3)
Heart Valve Diseases (Phase 3)
Hemostatic Disorders (Phase 3)
Hypertension (Phase 2)
Trials (2 total)
Trial APIs (4 total)